Amalgamated Bank Has $1.58 Million Holdings in Envista Holdings Co. (NYSE:NVST)

Amalgamated Bank cut its position in Envista Holdings Co. (NYSE:NVST) by 18.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 79,857 shares of the company’s stock after selling 17,607 shares during the period. Amalgamated Bank’s holdings in Envista were worth $1,578,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. M&G Plc boosted its position in Envista by 12.5% in the second quarter. M&G Plc now owns 306,253 shares of the company’s stock valued at $5,206,000 after buying an additional 33,923 shares in the last quarter. Harbor Capital Advisors Inc. raised its stake in shares of Envista by 287.4% in the second quarter. Harbor Capital Advisors Inc. now owns 169,648 shares of the company’s stock worth $2,821,000 after acquiring an additional 125,861 shares during the last quarter. Quadrature Capital Ltd raised its stake in shares of Envista by 110.9% in the first quarter. Quadrature Capital Ltd now owns 69,004 shares of the company’s stock worth $1,476,000 after acquiring an additional 36,290 shares during the last quarter. Nuance Investments LLC raised its stake in shares of Envista by 47.2% in the second quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock worth $117,048,000 after acquiring an additional 2,256,993 shares during the last quarter. Finally, WINTON GROUP Ltd bought a new position in shares of Envista in the second quarter worth about $7,019,000.

Analyst Upgrades and Downgrades

NVST has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research note on Thursday, October 31st. Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and boosted their target price for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Leerink Partnrs raised shares of Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Stifel Nicolaus boosted their price target on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. downgraded shares of Envista from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $23.00 to $16.00 in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $20.71.

Envista Stock Down 1.1 %

Shares of NYSE NVST opened at $20.52 on Wednesday. The stock has a market cap of $3.53 billion, a P/E ratio of -2.67, a P/E/G ratio of 2.87 and a beta of 1.30. The firm has a 50 day moving average price of $18.97 and a 200 day moving average price of $18.10. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $25.64.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.03. The company had revenue of $601.00 million during the quarter, compared to analysts’ expectations of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The business’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.43 earnings per share. Analysts expect that Envista Holdings Co. will post 0.71 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.